Nevala, W.K.; Geng, L.; Xie, H.; Stueven, N.A.; Markovic, S.N.
PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model. Int. J. Mol. Sci. 2025, 26, 3295.
https://doi.org/10.3390/ijms26073295
AMA Style
Nevala WK, Geng L, Xie H, Stueven NA, Markovic SN.
PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model. International Journal of Molecular Sciences. 2025; 26(7):3295.
https://doi.org/10.3390/ijms26073295
Chicago/Turabian Style
Nevala, Wendy K., Liyi Geng, Hui Xie, Noah A. Stueven, and Svetomir N. Markovic.
2025. "PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model" International Journal of Molecular Sciences 26, no. 7: 3295.
https://doi.org/10.3390/ijms26073295
APA Style
Nevala, W. K., Geng, L., Xie, H., Stueven, N. A., & Markovic, S. N.
(2025). PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model. International Journal of Molecular Sciences, 26(7), 3295.
https://doi.org/10.3390/ijms26073295